US › Healthcare

Volitionrx Ltd (VNRX)

US · Healthcare · Medical Devices

$0.28+3.64%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$398,657

Revenue YoY

-2.0%

Net profit

$-7.3M

EPS

$-0.78

EPS estimate

$-0.68

Net margin

-1,837.7%

EPS came in at -0.78 against a street estimate of -0.68 — a miss of 14.7%.

Key statistics

Market cap

$5.9M

Forward P/E

20.8

P/B

38.44

Book value

$-2.67

EPS (TTM)

$-3.85

52-week high

$14.80

52-week low

$0.31

50-day MA

$0.77

200-day MA

$3.13

Beta

1.09

Analyst view

Analysts rate Volitionrx Ltd a buy (5 buy, 1 hold, 0 sell out of 6) with an average price target of $16.57.

Shareholding

Insiders

5.45%

Institutions

17.57%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Volitionrx Ltd — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.